US Patent 11325902 Benzenesulfonamide compounds and their use as therapeutic agents
Patent 11325902 was granted and assigned to Xenon Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 13, 2020
0
Date of Patent
May 10, 2022
0
Patent Applicant
Patent Application Number
16927178
0
Patent Citations
Patent Citations Received
Patent Inventor Names
Verner Alexander Lofstrand
0
Alla Yurevna Zenova
0
Kristen Nicole Burford
0
Michael Scott Wilson
0
Thilo Focken
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11325902 Benzenesulfonamide compounds and their use as therapeutic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
